Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Notice Of 27Th Annual General Meeting Of The Company.

 This is to inform that the 27th Annual General Meeting ("AGM") of the members of the Company will be held on Thursday, September 30, 2021 at 11:00 a.m. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India, we hereby enclose the Notice of 27th Annual General Meeting of the Company which is being sent to the members through electronic mode. The same is also uploaded on the website of the Company at www.lincolnpharma.com.
07-09-2021
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Fixes Book Closure For Determining The Dividend, If Approved At The AGM

 Pursuant to the Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the 27th Annual General Meeting of the Company is scheduled to be held on Thursday, September 30, 2021 at 11:00 a.m. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM").
06-09-2021
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs
06-09-2021
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs
06-09-2021
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel
03-09-2021
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel
03-09-2021
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copies of published newspaper advertisement with respect to compliance with general circular No. 02/2021 dated January 13, 2021 issued by Ministry of Corporate Affairs, with respect to 27th Annual General Meeting of the Company scheduled to be held on Thursday, September 30, 2021 at 11:00 a.m. (IST) through Video Conferencing / Other Audio Visual Means. The said advertisement was published in the following newspapers: 1.The Indian Express, Ahmedabad Edition - In English; 2. Financial Express, Ahmedabad Edition - In Gujarati (Vernacular).
31-08-2021
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel
27-08-2021
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel
27-08-2021
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajnibhai Patel & Others
21-08-2021
Next Page
Close

Let's Open Free Demat Account